Steven Cohen Novavax Inc Put Options Transaction History

Point72 Asset Management, L.P.

  • $39.3 Billion
  • Q1 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$3.76 - $6.02 $376,000 - $602,000
100,000 Added 48.83%
304,800 $1.46 Million
Q4 2023

Feb 14, 2024
BUY
$4.8 - $7.67 $383,040 - $612,066
79,800 Added 63.84%
204,800 $983,000
Q3 2023

Nov 14, 2023
SELL
$6.81 - $9.74 $1.74 Million - $2.48 Million
-255,000 Reduced 67.11%
125,000 $905,000
Q2 2023

Aug 14, 2023
BUY
$6.67 - $9.52 $466,900 - $666,400
70,000 Added 22.58%
380,000 $2.82 Million
Q1 2023

May 15, 2023
BUY
$5.76 - $12.48 $1.79 Million - $3.87 Million
310,000 New
310,000 $2.15 Million

Others Institutions Holding NVAX

# of Institutions
243
Shares Held
76.1M
Call Options Held
5.06M
Put Options Held
7.19M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $931M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email